本页面由Tiger Trade Technology Pte. Ltd.提供服务

Ascendis Pharma A/S

216.32
-1.7800-0.82%
盘后216.320.00000.00%17:21 EST
成交量:69.88万
成交额:1.52亿
市值:133.46亿
市盈率:-47.66
高:221.80
开:217.85
低:213.02
收:218.10
52周最高:242.00
52周最低:124.06
股本:6,169.52万
流通股本:6,008.34万
量比:0.69
换手率:1.16%
股息:- -
股息率:- -
每股收益(TTM):-4.5384
每股收益(LYR):-6.7615
净资产收益率:-818.43%
总资产收益率:-7.69%
市净率:-64.59
市盈率(LYR):-31.99

数据加载中...

2026/02/11

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2026/01/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/09/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/05/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/05/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/05/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/05/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities